|
|
|
 |
Last Updated: Nov 2, 2013 - 11:52:55 AM |
Latest Research
NIH renews funding for University of Maryland vaccine research
Baltimore, MD - September 26, 2013 - The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has successfully competed for and received a renewed contract to conduct basic research and clinical studies of vaccines, diagnostics, and therapeutics. Support for this work to combat existing and emerging infectious diseases is provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Sep 26, 2013 - 4:00:00 AM
|
Latest Research
Bird flu mutation study offers vaccine clue
Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.
Apr 8, 2013 - 4:00:00 AM
|
Latest Research
Institute of Medicine report details for monitoring safety of childhood immunization schedule
ANN ARBOR -- A review of the available evidence underscores the safety of the federal childhood immunization schedule, according to a report released today by the Institute of Medicine. University of Michigan population ecologist Pejman Rohani served on the 13-person committee that wrote the report.
Jan 16, 2013 - 5:00:00 AM
|
Latest Research
Winning the battle against leukaemia: Positive early results in clinical trial for DNA vaccine
Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.
Dec 7, 2012 - 5:00:00 AM
|
Latest Research
Influenza vaccine may reduce risk of heart disease and death
Getting a flu shot may not only protect you from getting sick, it might also prevent heart disease.
Oct 28, 2012 - 4:00:00 AM
|
Latest Research
NIH-funded study to test pneumococcal vaccine in older adults
Researchers plan to see if a higher dose of a pneumococcal vaccine will create a stronger immune response in older adults who received an earlier generation vaccine against pneumonia and other pneumococcal diseases.
Oct 15, 2012 - 4:00:00 AM
|
Latest Research
Cardiff scientists bid to develop anthrax vaccine to counteract world bioterrorism threat
A team of Cardiff University scientists is leading new research to develop a vaccine against anthrax to help counteract the threat of bioterrorism.
Sep 17, 2012 - 4:00:00 AM
|
Latest Research
UCSF researchers identify a potential new HIV vaccine/therapy target
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after infection were better able to control the virus.
May 30, 2012 - 4:00:00 AM
|
Latest Research
A*STAR scientists discover 'switch' to boost anti-viral response to fight infectious diseases
Singapore scientists from Bioprocessing Technology Institute (BTI) under the Agency of Science, Technology and Research (A*STAR) have for the first time, identified the molecular 'switch' that directly triggers the body's first line of defence against pathogens, more accurately known as the body's innate immunity. The scientists found that this 'switch' called Bruton's tyrosine kinase (BTK) when turned on, activates the production of interferons - a potent class of virus killers that enables the body to fight harmful pathogens such as dengue and influenza viruses.
May 11, 2012 - 4:00:00 AM
|
Latest Research
A*STAR scientists discover special class of natural fats stimulates immune cells to fight diseases
An international research team led by scientists from Singapore Immunology Network (SIgN) under the Agency of Science, Technology and Research (A*STAR) discovered that a special class of fatty molecules is essential for activating a unique group of early-responding immune cells. This study sheds light on how recognition of fatty molecules by immune cells could protect from infection, allergic reactions, autoimmune diseases and cancer. More importantly, it offers new opportunities to exploit the use of these stimulatory fatty molecules in therapeutic interventions, such as the development of new vaccines and drugs targetted for autoimmune diseases.
Apr 2, 2012 - 4:00:00 AM
|
Latest Research
Tuberculosis international conference: April 13-14 at Emory University
Leading international experts in tuberculosis and related diseases from at least 10 countries will gather at a Human Immunity to Tuberculosis conference April 13-14 in Atlanta. The meeting will take place at the Emory Conference Center, 1615 Clifton Rd., Atlanta, GA 30329.
Mar 22, 2012 - 4:00:00 AM
|
Latest Research
New research could significantly reduce the need for clinical animal testing
University of Southampton researchers are investigating innovative methods of testing drugs that will reduce the need for involving animals.
Mar 8, 2012 - 5:00:00 AM
|
Latest Research
HIV/AIDS vaccine shows long-term protection against multiple exposures in non-human primates
An Atlanta research collaboration may be one step closer to finding a vaccine that will provide long-lasting protection against repeated exposures to human immunodeficiency virus (HIV). Scientists at Emory University and GeoVax Labs, Inc. developed a vaccine that has protected nonhuman primates against multiple exposures to simian immunodeficiency virus (SIV) given in three clusters over more than three years. SIV is the nonhuman primate version of HIV.
Mar 7, 2012 - 5:00:00 AM
|
Latest Research
University of Alberta researcher to announce 'signifcant step' towards Hep C vaccine
Edmonton -- A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon. Currently, there are no vaccines against the disease available.
Feb 15, 2012 - 5:00:00 AM
|
Latest Research
Continuing uncertainties surround anti-influenza drug
Incomplete availability of data has hampered a thorough assessment of the evidence for using the anti-influenza drug oseltamivir, a Cochrane Review has found. However, after piecing together information from over 16,000 pages of clinical trial data and documents used in the process of licensing oseltamivir (Tamiflu) by national authorities, a team of researchers has raised critical questions about how well the drug works and about its reported safety profile. The new analysis shows inconsistencies with published reports, and describes possible under-reporting of drug-related side-effects in some published trial reports. While the drug did reduce the time to first alleviation of symptoms by an average of 21 hours, it did not reduce the number of people who went on to need hospital treatment. Results from the reanalysis of data also raise questions about how the drug works as an influenza virus inhibitor.
Jan 17, 2012 - 5:00:00 AM
|
Latest Research
Best way to boost adult immunizations is through office-based action, study finds
Promoting immunizations as a part of routine office-based medical practice is needed to improve adult vaccination rates, a highly effective way to curb the spread of diseases across communities, prevent needless illness and deaths, and lower health care costs, according to a new RAND Corporation study.
Jan 11, 2012 - 5:00:00 AM
|
Latest Research
'Pep talk' can revive immune cells exhausted by chronic viral infection
Chronic infections by viruses such as HIV or hepatitis C eventually take hold because they wear the immune system out, a phenomenon immunologists describe as exhaustion.
Dec 13, 2011 - 5:00:00 AM
|
Latest Research
Study finds shifting disease burden following universal Hib vaccination
[EMBARGOED FOR NOV. 11, 2011] Vaccination against Haemophilus influenzae type b, or Hib, once the most common cause of bacterial meningitis in children, has dramatically reduced the incidence of Hib disease in young children over the past 20 years, according to a study published in Clinical Infectious Diseases and available online (
Nov 11, 2011 - 5:00:00 AM
|
Latest Research
Dirt prevents allergy
Oversensitivity diseases, or allergies, now affect 25 per cent of the population of Denmark. The figure has been on the increase in recent decades and now researchers at the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC), University of Copenhagen, are at last able to partly explain the reasons.
Nov 2, 2011 - 4:00:00 AM
|
Latest Research
NIH modifies 'VOICE' HIV prevention study in women
A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective.
Sep 28, 2011 - 4:00:00 AM
|
Latest Research
Scientists disarm HIV in step towards vaccine
Researchers have found a way to prevent HIV from damaging the immune system, in a new lab-based study published in the journal Blood. The research, led by scientists at Imperial College London and Johns Hopkins University, could have important implications for the development of HIV vaccines.
Sep 19, 2011 - 4:00:00 AM
|
Latest Research
Pharmacists need to provide better information to teenagers on risks and benefits of medicines
Hyderabad, India: A large proportion of teenagers regularly and frequently take some form of medication without receiving targeted information about the risks and benefits, according to a review of current research, to be presented at the annual congress of the International Pharmaceutical Federation (FIP) tomorrow (Tuesday).
Sep 4, 2011 - 4:00:00 AM
|
Latest Research
Researchers on the trail of a treatment for cancer of the immune system
Infection with Epstein Barr means that the B cells, which are the primary memory cells of the immune system, are hi-jacked.
Aug 19, 2011 - 4:00:00 AM
|
Latest Research
NIH funds Emory-led consortium to advance AIDS vaccine research
A consortium of leading vaccine researchers at Emory University and partner institutions has received a National Institutes of Health (NIH) grant aimed at developing an effective HIV/AIDS vaccine.
Jul 18, 2011 - 4:00:00 AM
|
Latest Research
Lack of clarity about HPV vaccine and the need for cervical cancer screening
The research will be presented today [Thursday 7 July] at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol.
Jul 6, 2011 - 4:00:00 AM
|
Latest Research
Adjuvant combo shows potential for universal influenza vaccine
Researchers at National Jewish Health have discovered how to prime a second arm of the immune system to potentially boost influenza vaccine effectiveness. A combination of two adjuvants, chemicals used to boost the effectiveness of some vaccines, induced CD8, or killer, T cells to join antibodies in response to influenza infection. Since the killer T cells targeted a highly conserved protein that does not change from year to year, the adjuvant strategy suggests potential for a universal flu vaccine.
Jun 7, 2011 - 4:00:00 AM
|
Latest Research
Researchers discover biochemical weakness of malaria parasite -- vaccine to be developed
Every year, 10,000 pregnant women and up to 200,000 newborn babies are killed by the malaria parasite. Doctors all around the globe have for years been looking in vain for a medical protection, and now researchers from the University of Copenhagen have found the biochemically weakness of the lethal malaria parasite, and will now start developing a vaccine to combat pregnancy related malaria.
Jun 7, 2011 - 4:00:00 AM
|
Latest Research
Clinical trial of malaria vaccine begins in Africa
The vaccine, RTS,S, developed by GlaxoSmithKline (GSK) Biologicals and PATH Malaria Vaccine Initiative (MVI), is currently in phase III clinical trials and has previously reduced episodes of malaria in infants and young children by more than 50%. The Liverpool team, in collaboration with the University College of Medicine, Malawi, are working in Blantyre over the next three years to investigate how to maximise its effectiveness when delivered through the childhood immunisation programme.
May 25, 2011 - 4:00:00 AM
|
Latest Research
Antibodies help protect monkeys from HIV-like virus, NIH scientists show
WHAT: Using a monkey model of AIDS, scientists have identified a vaccine-generated immune-system response that correlates with protection against infection by the monkey version of HIV, called simian immunodeficiency virus (SIV). The researchers found that neutralizing antibodies generated by immunization were associated with protection against SIV infection. This finding marks an important step toward understanding how an effective HIV vaccine could work, according to scientists who led the study at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
May 5, 2011 - 4:00:00 AM
|
Latest Research
Systematic effort helps hospital raise employee flu vaccination rates
A systematic effort to improve flu vaccination rates for healthcare workers has increased flu vaccinations rates from 59 percent to 77 percent at the University Health System (UHS) in San Antonio. A report detailing their interventions to increase vaccination was published in the June issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
May 4, 2011 - 4:00:00 AM
|
Latest Research
Nasal spray vaccines more effective against flu
Nasal vaccines that effectively protect against flu, pneumonia and even bioterrorism agents such as Yersinia pestis that causes the plague, could soon be a possibility, according to research presented at the Society for General Microbiology's Spring Conference in Harrogate. Professor Dennis Metzger describes how including a natural immune chemical with standard vaccines can boost their protective effect when delivered through the nose.
Apr 11, 2011 - 4:00:00 AM
|
Latest Research
Allergy vaccine is nothing to sneeze at
Monash University researchers are working on a vaccine that could completely cure asthma brought on by house dust mite allergies.
Mar 21, 2011 - 4:00:00 AM
|
Latest Research
New vaccine technology protects mice from hepatitis C virus
Immunology: Three percent of the world's population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it's the most frequent cause of liver transplants in Denmark. Since the virus mutates strongly, we have no traditional vaccine, but researchers at the University of Copenhagen are now the first to succeed in developing a vaccine, which provides future hope for medical protection from this type of hepatitis.
Feb 23, 2011 - 5:00:00 AM
|
Latest Research
Saint Louis University findings: Don't pitch stockpiled avian flu vaccine
ST. LOUIS -- A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.
Feb 9, 2011 - 5:00:00 AM
|
Health
:
Public Health
Genetic study of bedbugs may help identify pesticide resistance genes
OhioState University entomologists have conducted the first genetic study of bedbugs, paving the road to the identification of potential genes associated with pesticide resistance and possible new control methods for the troublesome insect, whose sudden resurgence in the United States has led to a public health scare.
Jan 19, 2011 - 5:08:01 PM
|
Latest Research
Researchers unzip MRSA and discover route for vaccine
University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.
Jan 16, 2011 - 5:00:00 AM
|
Latest Research
Mother Nature and bioterrorists: Rochester battles both with $11.9 million award
Flu viruses are a great threat, whether they stem from Mother Nature or are modified by human hands to create a deadly bioweapon. The University of Rochester Medical Center will tackle both scenarios head on with a five-year contract, totaling approximately $11.9 million, from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract will further research into how we can use computer modeling to find ways of boosting human immune responses against and identify new areas of investigation into treatments for a variety of potentially lethal viruses.
Nov 10, 2010 - 5:00:00 AM
|
Latest Research
Cow vaccines go vroom
In much of Africa, a herd of cattle is more than just cows. It's a savings account, protein store, dowry, funeral fund, symbol of wealth, and hedge against drought. For many smallholder farmers, the loss of even a single cow to disease can spell ruin.
Aug 17, 2010 - 4:00:00 AM
|
Latest Research
NIH launches effort to define markers of human immune responses
A new nationwide research initiative has been launched to define changes in the human immune system, using human and not animal studies, in response to infection or to vaccination. Six U. S.-based Human Immune Phenotyping Centers will receive a total of $100 million over five years to conduct this research.
Aug 11, 2010 - 4:00:00 AM
|
Latest Research
UR discovers new way to boost vaccines, seeks patent
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body's response to vaccinations.
Aug 4, 2010 - 4:00:00 AM
|
Latest Research
New inhalable measles vaccine may lead to vaccines for other diseases
A team of researchers led by the University of Colorado at Boulder believe a dry powder, inhalable vaccine developed for measles prevention and slated for human clinical trials later this year in India will lead to other inhalable, inexpensive vaccines for illnesses ranging from tuberculosis to cervical cancer.
May 5, 2010 - 4:00:00 AM
|
Latest Research
OB/GYN offices may offer ideal venue for improving vaccine rates among women
DURHAM, NC -- Obstetrician/gynecologist offices may be the ideal venue for boosting vaccination rates among women, say researchers at Duke University Medical Center. They reported today on a successful pilot program focused on providing HPV (human papillomavirus) and Tdap (tetanus, diphtheria, pertussis) vaccines to non-pregnant and post-partum women.
Apr 20, 2010 - 4:00:00 AM
|
Latest Research
IOM report on national vaccine plan
WASHINGTON -- While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan. The revised plan should include a strategy to accelerate development of high-priority vaccines, said the committee that wrote the report. In addition, it should emphasize the importance of expanding funding for safety research and monitoring, and include the development of a national communications strategy to clarify the importance of vaccines and bolster public confidence in the immunization system.
Dec 11, 2009 - 5:00:00 AM
|
Latest Research
American adults receiving flu vaccine at about the same rate as in 2008, study finds
American adults are not being vaccinated against the seasonal flu any more often than they were last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus, according to a new RAND Corporation study.
Dec 9, 2009 - 5:00:00 AM
|
Latest Research
Progress made on group B streptococcus vaccine
WHAT: Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. GBS is the most common cause of sepsis and meningitis in newborns in the United States, according to the Centers for Disease Control and Prevention (CDC). It can also cause severe illness in pregnant women, the elderly and adults with chronic illnesses. Colonization of the genital or gastrointestinal tract is a critical risk factor for infections due to GBS.
Oct 30, 2009 - 4:00:00 AM
|
Latest Research
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both part of the National Institutes of Health.
Oct 9, 2009 - 4:00:00 AM
|
Latest Research
Lessons learned from H1N1 virus pandemic
A comprehensive study has revealed, for the first time, the impact of swine flu on the health of the general public in Australia and New Zealand.
Oct 8, 2009 - 4:00:00 AM
|
Latest Research
NIAID announces vaccine adjuvant discovery contracts
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.
Oct 8, 2009 - 4:00:00 AM
|
Latest Research
Research ensures 50 million vaccinated against deadly brain infection
Research at the University of Liverpool has supported the vaccination of more than 50 million people against a zoonotic brain infection that affects thousands of children across Asia every year.
Oct 6, 2009 - 4:00:00 AM
|
Latest Research
HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
Sep 24, 2009 - 4:00:00 AM
|
|
|
|
|
| Health |
Gathering information about food is not top priority for individuals with high metabolisms
|
NIH renews funding for University of Maryland vaccine research
|
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
|
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
|
Vitamin D supplementation may delay precocious puberty in girls
|
Study: Pedometer program helps motivate participants to sit less, move more
|
Fish oil may stall effects of junk food on brain
|
Intake of low energy dense food better than skipping meals
|
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
|
Molecular hub links obesity, heart disease to high blood pressure
|
| | Healthcare |
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
|
Flu pandemic infected one in five
|
Stigma preventing leprosy-cured from getting jobs
|
Measles, Mumps make a comeback in US
|
Melinda Gates calls on Akhilesh Yadav
|
'Movies, TV impact tobacco users more than newspapers'
|
Rockland to open three new hospitals in NCR
|
Spice Global enters healthcare business with hospital in Delhi
|
Delhi to expedite recruitment of doctors
|
India adds spice to US life, keeps it healthy
|
| | Latest Research |
How do consumers see a product when they hear music?
|
Drug activates virus against cancer
|
Bone loss associated with increased production of ROS
|
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
|
Crystal methamphetamine use by street youth increases risk of injecting drugs
|
Johns Hopkins-led study shows increased life expectancy among family caregivers
|
Moderate to severe psoriasis linked to chronic kidney disease, say experts
|
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
|
Simple blood or urine test to identify blinding disease
|
Physician job satisfaction driven by quality of patient care
|
| | Medical News |
NHRC issues notice to Kerala over infant deaths
|
Advanced breast cancer detecting machine comes to India
|
'Dispel myths about vitiligo'
|
NHRC summons Odisha chief secretary
|
Woman dies of swine flu in UP
|
Maharashtra, GE to modernise rural health care
|
Hypertension: India's silent killer
|
Need cautious effort to eradicate polio: Experts
|
Ayurveda experts develop online personalised health regimen
|
Soon a detailed study on 'diabesity': Doctors
|
| | Special Topics |
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
|
Worrying rise in number of medical students in prostitution over last 10 years
|
Behold India's unfolding democratic revolution
|
Chinese woman cuts open her belly to save surgery cost
|
Improved Sense of Smell Produced Smarter Mammals
|
Two-year-old world's first to have extra DNA strand
|
172,155 kidney stones removed from one patient!
|
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
|
|
